CPC A61K 31/445 (2013.01) [A61K 31/138 (2013.01); A61K 31/198 (2013.01); A61K 31/216 (2013.01); A61K 31/4184 (2013.01); A61K 31/437 (2013.01); A61K 31/4545 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); A61K 31/498 (2013.01); A61K 31/517 (2013.01); A61K 31/558 (2013.01); A61K 31/565 (2013.01); A61K 31/567 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 45/06 (2013.01)] | 6 Claims |
1. A method for treating chemotherapy induced peripheral neuropathic pain (CIPNP) in a subject in need of the treatment, the method comprising:
administering to the subject a therapeutically effective amount of a cytochrome P450 epoxygenase 2J2 (CYP2J2) antagonist to treat the CIPNP, the CYP2J2 antagonist selected from the group consisting of estradiol, clobetasol propionate, doxazosin mesylate, fenofibrate, levonorgestrel, aripiprazole, halcinonide, telmisartan, levothyroxine-Na, alosetron-HCl, fluocinonide, and liothyronine-Na.
|